252
Views
60
CrossRef citations to date
0
Altmetric
Original

Pycnogenol® as an Adjunct in the Management of Childhood Asthma

, Ph.D. , M.D., , M.D., , D.O., , M.S., R.D., , Ph.D. & , B.S., R.N.
Pages 825-832 | Published online: 02 Jul 2009
 

Abstract

A randomized, placebo‐controlled, double‐blind study involving 60 subjects, aged 6–18 years old, was conducted over a period of 3 months to determine the effect of Pycnogenol® (a proprietary mixture of water‐soluble bioflavonoids extracted from French maritime pine) on mild‐to‐moderate asthma. After baseline evaluation, subjects were randomized into two groups to receive either Pycnogenol® or placebo. Subjects were instructed to record their peak expiratory flow with an Assess® Peak Flow Meter each evening. At the same time, symptoms, daily use of rescue inhalers (albuterol), and any changes in oral medications were also recorded. Urine samples were obtained from the subjects at the end of the run‐in period, and at 1‐, 2‐, and 3‐month visits. Urinary leukotriene C4/D4/E4 was measured by an enzyme immunoassay. Compared with subjects taking placebo, the group who took Pycnogenol® had significantly more improvement in pulmonary functions and asthma symptoms. The Pycnogenol® group was able to reduce or discontinue their use of rescue inhalers more often than the placebo group. There was also a significant reduction of urinary leukotrienes in the Pycnogenol® group. The results of this study demonstrate the efficacy of Pycnogenol® as an adjunct in the management of mild‐to‐moderate childhood asthma.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.